Navigation Links
African-American, Caucasian women should take identical vitamin D doses
Date:2/11/2013

Chevy Chase, MD African-American women battling vitamin D deficiencies need the same dose as Caucasian women to treat the condition, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

Although women with darker skin tones tend to have lower levels of the biomarker used to measure Vitamin D levels, called 25-hydroxyvitamin D or 25OHD, the study found that older African-American and Caucasian women responded in the same way when they received vitamin D supplements.

Unlike many vitamins that are absorbed primarily from foods, the body's main source of vitamin D is sunlight. Vitamin D deficiency, which is primarily caused by inadequate exposure to sunlight and very poor diet, can result in abnormalities in calcium, phosphorus and bone metabolism. Vitamin D deficiency can cause rickets in children or a bone-softening condition called osteomalacia and muscle weakness in adults.

In a double-blind study that gave varying vitamin D doses to African-American and Caucasian women of similar body size, levels of the 25OHD biomarker were very similar. The findings suggest that vitamin D absorption and metabolism is the same in both groups. Researchers concluded that African-American women tend to have lower levels of the biomarker 25OHD because they naturally produce less vitamin D in the skin after sunlight exposure.

"African-American women don't have to worry about taking larger doses of vitamin D to compensate," said J. Chris Gallagher, MD, of Creighton University School of Medicine in Omaha, Neb., and lead author of the study. "They should follow the current medical guidelines for vitamin D supplementation suggested recently by the Institute of Medicine."

The Endocrine Society has issued a separate set of clinical practice guidelines governing vitamin D dosage. The guidelines are available at http://www.endo-society.org/guidelines/final/upload/FINAL-Standalone-Vitamin-D-Guideline.pdf.

Previously there was no research in minority populations to determine whether the same guidelines applied to them. Researchers designed this study to develop dosing guidelines for older African-American women. The study, which looked at vitamin D doses in 110 African-American women between the ages of 57 and 90, was the first randomized controlled dose response study conducted in this population.

"We saw a real need to study optimal vitamin D doses in African-American women and help their health care professionals make informed medical decisions," Gallagher said.

Although exposure to sunlight increases vitamin D levels, concerns about melanoma and other types of skin cancer necessitate avoidance of excessive exposure to the sun.


'/>"/>

Contact: Jenni Glenn Gingery
jgingery@endo-society.org
301-941-0240
The Endocrine Society
Source:Eurekalert

Related biology news :

1. Cancer risk for African-American women with benign breast disease factors Wayne State finds
2. Few pregnant women treated for sexually transmitted infections
3. Geneviève Almouzni to receive the 2013 FEBS
4. EMBO Women in Science Award
5. Abuse during childhood linked to uterine fibroids in African-American women
6. Women must do more to reap same positive health outcomes as men, MU research suggests
7. Vaginal delivery is the safest option for women with pelvic girdle pain
8. Scientists pinpoint molecular signals that make some women prone to miscarriage
9. Virtual women reveal more skin, regardless of body proportions
10. Overweight pregnant women not getting proper weight-gain advice
11. Abuse during childhood linked to adult-onset asthma in African-American women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... Calif. , Feb. 2, 2016  Based ... market, Frost & Sullivan recognizes US-based Intelligent Retinal ... Frost & Sullivan Award for New Product Innovation. ... in North America , is ... the rapidly growing diabetic retinopathy market. The IRIS ...
(Date:1/28/2016)... Jan. 28, 2016 Synaptics (NASDAQ: SYNA ), a ... its second quarter ended December 31, 2015. ... of fiscal 2016 increased 2 percent compared to the comparable quarter ... of fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... income for the first quarter of fiscal 2016 grew 9 percent ...
(Date:1/22/2016)... DUBLIN , January 22, 2016 ... has announced the addition of the  ... to their offering. --> ... of the  "Global Behavioral Biometric Market ... --> Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... China , Feb. 4, 2016 Beike ... and various medical institutions attended a ceremony in late ... integrative, personalized cell therapy in 2016. ... "Shenzhen Clinical Translation Platform for Personalized Cell Therapy" was ... Regional Cell Production Center, both subsidiaries of Beike Biotechnology ...
(Date:2/4/2016)... and MENLO PARK, Calif. , Feb. 4, ... and the "Company"), a biopharmaceutical company focused on the development ... will present at the 18 th Annual BIO ... at 10:00 a.m. EST in New York, NY ... and CEO, will provide an update on the ongoing clinical ...
(Date:2/4/2016)... Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of targeted antiviral therapies, announced today ... Conference 2016, to be held February 8-9, 2016, at ... 2016 Disruptive Growth & Healthcare Conference, taking place in ... 2016. James Sapirstein , Chief Executive Officer ...
(Date:2/4/2016)... BEIJING , Feb. 4, 2016 Sinovac ... ), a leading provider of biopharmaceutical products in ... committee of its board of directors received on February ... 3, 2016, from a consortium comprised of PKU V-Ming ... Sinobioway Biomedicine Co., Ltd., CICC Qianhai Development ( ...
Breaking Biology Technology: